Introduction
Overview of main HSP clinical categories
Gene | Protein | Inherited | OMIM | Comment | P/C* | Clinical features of complex forms |
---|---|---|---|---|---|---|
SPG1/L1CAM | L1-cell adhesion molecule | XL | #303350 | C | 1. MASA syndrome, 2. X-linked hydrocephalus, 3. X-linked complicated HSP | |
SPG2/PLP1 | Proteolipid protein 1 | XL | #312920 | P/C | 1. Pure HSP, 2. complex HSP, 3. Pelizaeus–Merzbacher disease | |
SPG3A/ATL1 | Atlastin1 | AD | #182600 | P | ||
SPG4/SPAST | Spastin | AD | #182601 | P | ||
SPG5A/CYP7B1 | 25-hydroxycholesterol 7-alpha-hydroxylase | AR | #270800 | P | ||
SPG6/NIPA1 | NIPA1 | AD | #600363 | P | ||
SPG7 | Paraplegin | AR | #607259 | P/C | Cerebellar ataxia, optic atrophy, deafness, amyotrophy | |
SPG8/KIAA0196 | Strumpellin | AD | #603563 | P | ||
SPG9 | – | AD | %601162 | C | Cataracts, motor neuropathy, skeletal abnormalities and gastro-oesophageal reflux. | |
SPG10/KIF5A | Kinesin heavy chain 5A | AD | #604187 | P/C | Peripheral neuropathy, amyotrophy, mental retardation, parkinsonism | |
SPG11 | Spatacsin | AR | #604360 | C | HSP with thin corpus callosum. Peripheral neuropathy, intellectual disability, cognitive decline, amyotrophy, pseudobulbar involvement, cerebellar involvement, parkinsonism, dystonia | |
SPG12/RTN2 | Reticulon2 | AD | #604805 | P | ||
SPG13/HSPD1 | Heat shock 60 kDa protein 1 | AD | #605280 | P | ||
SPG14 | – | AR | %605229 | C | Intellectual disability, motor neuropathy | |
SPG15 | Spastizin | AR | #270700 | C | HSP with thin corpus callosum. Peripheral neuropathy, intellectual disability, cognitive decline, amyotrophy, pseudobulbar involvement, cerebellar involvement, parkinsonism, dystonia, pigmentary maculopathy (Kjellin syndrome). | |
SPG16 | – | XLR | %300266 | C | Spastic quadraplegia, intellectual disability, cerebellar ataxia, optic atrophy, nystagmus, bowel and bladder dysfunction. | |
SPG17/BSCL2 | Seipin | AD | #270685 | C | Silver syndrome; HSP with distal amyotrophy. Overlaps with HMSN V. | |
SPG18/ERLIN2 | ER lipid raft associated 2 | AR | #611225 | C | Epilepsy, intellectual disability, pseudobulbar palsy, joint contractures | |
SPG19 | AD | %607152 | P | |||
SPG20/SPARTIN | Spartin | AR | #275900 | C | Troyer syndrome: dysarthria, pseudobulbar palsy, intellectual disability, amyotrophy, short stature | |
SPG21/MAST | Maspradin | AR | #248900 | C | Mast syndrome: progressive dementia, cerebellar signs, extra-pyramidal involvement, thin corpus callosum. | |
SPG22 | SLC16A2 | XLR | #300523 | C | Allan-Herndon-Dudley syndrome | |
SPG23 | – | AR | %270750 | C | Disordered skin pigmentation, peripheral neuropathy | |
SPG24 | – | AR | %607584 | P | ||
SPG25 | – | AR | %608220 | C | Disc herniation | |
SPG26/B4GALNT1 | Beta-1,4 N-acetylgalactosaminyltransferase 1 | AR | #609195 | C | Intellectual disability, peripheral neuropathy, dysarthria, cerebellar signs, extrapyramidal involvement, cortical atrophy | |
SPG27 | – | AR | %609041 | P | ||
SPG28/DDHD1 | Phospholipase DDHD1 | AR | #609340 | P/C | Cerebellar eye signs, peripheral neuropathy | |
SPG29/KIF1A | Kinesin family member 1A | AD | %609727 | Sensorineural hearing impairment, neonatal hyperbilirubinemia, hiatus hernia | ||
SPG30 | – | AR | #610357 | C | Cerebellar signs, peripheral neuropathy | |
SPG31/REEP1 | Receptor expression-enhancing protein 1 | AD | #610250 | P | ||
SPG32 | – | AR | %611252 | C | Cognitive impairment, thin corpus callosum, cortical atrophy, cerebellar atrophy, pontine dysraphia. | |
[SPG33/ZFYVE27] | [Protrudin] | [AD] | #610244 | Mutation may not be pathogenic-present in control populations | [P] | |
SPG34 | – | XLR | %300750 | P | ||
SPG35/FA2H | Fatty acid 2-hydroxylase | AR | #612319 | C | Dysarthria, intellectual decline, leukodystrophy, dystonia, optic atrophy, seizures, cerebellar signs, thin corpus callosum. May cause brain iron accumulation. | |
SPG36 | – | AD | %613096 | C | Lower limb sensory changes | |
SPG37 | – | AD | %611945 | P | ||
SPG38 | – | AD | %612335 | C | Similar to Silver syndrome (see SPG17) | |
SPG39/PNPLA6 | Neuropathy target esterase | AR | #612020 | C | Distal amyotrophy, cerebellar atrophy. Allelic with Boucher–Neuhauser syndrome (spinocerebellar ataxia, hypogonadotropic hypogonadism, chorioretinal dystrophy) | |
SPG40 | – | |||||
SPG41 | – | AD | %613364 | Single family with lod score <3 | ||
SPG42/SLC33A1 | Acetyl-coenzyme A transporter 1 | AD | #612539 | P | ||
SPG43/C19orf12 | C19orf12 | AR | #615043 | P/C | Upper limb involvement, distal amyotrophy. May also be associated with brain iron accumulation | |
SPG44/GJC2 | Gap junction gamma-2 protein | AR | #613206 | C | Cerebellar signs, seizures, cognitive impairment, scoliosis, leukodystrophy, thin corpus callosum. | |
SPG45/NT5C2 | Cytosolic purine 5’-nucleotidase | AR | #613162 | C | Optic atrophy, thin corpus callosum, intellectual disability | |
SPG46/GBA2 | Non-lysosomal glucosylceramidase | AR | #614409 | C | Cerebellar signs, intellectual impairment, cerebral atrophy, cerebellar atrophy, thin corpus callosum, pseudobulbar involvement, cataracts. | |
SPG47/AP4B1 | AP-4 complex subunit beta-1 | AR | #614066 | C | Neonatal hypotonia, severe intellectual impairment, dysmorphic features, thin corpus callosum. | |
SPG48/AP5Z1 | AP-5 complex subunit zeta-1 | AR | #613647 | C | Urinary incontinence | |
SPG49/TECPR2 | Tectonin beta-propeller repeat-containing protein 2 | AR | #615031 | C | Intellectual impairment, dysmorphic features, cerebral atrophy, cerebellar atrophy, thin corpus callosum | |
SPG50/AP4M1 | AP-4 complex subunit mu-1 | AR | #612936 | C | Neonatal hypotonia, severe intellectual impairment, pseudobulbar signs, microcephaly, cerebellar atrophy | |
SPG51/AP4E1 | AP-4 complex subunit epsilon-1 | AR | #613744 | C | Neonatal hypotonia, severe intellectual impairment,dysmorphic features, seizures, cortical atrophy, cerebellar atrophy, microcephaly | |
SPG52/AP4S1 | AP-4 complex subunit sigma-1 | AR | #614067 | C | Neonatal hypotonia, severe intellectual impairment, microcephaly, dysmorphic features, short stature | |
SPG53/VPS37A | Vacuolar protein sorting-associated protein 37A | AR | #614898 | C | Intellectual disability | |
SPG54/DDHD2 | Phospholipase DDHD2 | AR | #615033 | C | Intellectual disability, dysarthria, dysphagia, optic hypoplasia, thin corpus callosum and white matter changes, short stature | |
SPG55/C12ORF65 | C12orf65 | AR | #615035 | C | Peripheral neuropathy, optic atrophy, intellectual disability | |
SPG56/CYP2U1 | Cytochrome P450 2U1 | AR | #615030 | P/C | Upper limb involvement, peripheral neuropathy, intellectual impairment, thin corpus callosum | |
SPG57/TFG | Protein TFG | AR | #615658 | C | Optic atrophy, peripheral neuropathy | |
SPG58/SPAX2/KIF1C | Kinesin-like protein KIF1C | AR | #611302 | C | Cerebellar ataxia | |
SPG59/USP8 | Ubiquitin carboxyl-terminal hydrolase 8 | AR | *603158 | VUS | P | |
SPG60/WDR48 | WD repeat-containing protein 48 | AR | *612167 | VUS | C | Nystagmus, peripheral neuropathy, intellectual disability |
SPG61/ARL6IP1 | ADP-ribosylation factor-like protein 6-interacting protein 1 | AR | #615685 | C | Peripheral neuropathy | |
SPG62 | – | |||||
SPG63/AMPD2 | AMP deaminase 2 | AR | #615686 | P/C | White matter changes in corpus callosum | |
SPG64/ENTPD1 | Ectonucleoside triphosphate diphosphohydrolase 1 | AR | #615683 | C | Dysarthria, intellectual disability, microcephaly, delayed puberty | |
SPG65 | Duplicate of SPG45 | |||||
SPG66/ARSI | Arylsulfatase I | AR | *610009 | VUS | C | Thin corpus callosum, cerebellar hypoplasia, colpocephaly, peripheral neuropathy |
SPG67/PGAP1 | GPI inositol-deacylase | AR | *611655 | VUS | C | Intellectual disability, tremor, absent corpus callosum, defective myelination |
SPG68/FLRT1 | leucine-rich repeat transmembrane protein FLRT1 | AR | *604806 | VUS | C | Optic atrophy, peripheral neuropathy |
SPG69/WARBM2/RAB3GAP2 | Rab3 GTPase-activating protein non-catalytic subunit | AR | *609275 | C | Warburg micro syndrome, Martsolf syndrome | |
SPG70/MARS | Methionine-tRNA ligase, cytoplasmic | AR | *156560 | VUS | P/C | Mild intellectual disability |
SPG71/ZFR | Zinc finger RNA-binding protein | AR | *615635 | VUS | C | Thin corpus callosum |
SPG72/REEP2 | Receptor expression-enhancing protein 2 | AR/AD | #615625 | P | ||
Spastic ataxias | ||||||
SPAX1/VAMP1 | Vesicle-associated membrane protein 1 | AD | #108600 | SPAX | ||
SPAX2/SPG58/KIF1C | Kinesin-like protein KIF1C | AR | #611302 | SPAX | ||
SPAX3/MARS2 | Methionine-tRNA ligase, mitochondrial | AR | #611390 | SPAX | ||
SPAX4/MTPAP | Poly(A) RNA polymerase, mitochondrial | AR | #613672 | SPAX | ||
SPAX5/AFG3L2 | AFG3-like protein 2 | AR | #614487 | SPAX | ||
SPAX6/SACS | Sacsin | AR | #270550 | SPAX | Spastic ataxia of Charlevoix-Saguenay | |
EXOSC3/PCH1B | Exosome complex component RRP40 | AR | *606489 | Allelic with pontocerebellar hypoplasia |
Genetics of HSPs
Pure HSP phenotype
Gene | Reported frequency in familial cases | Frequency in sporadic cases | Frequency in unselected cases |
---|---|---|---|
SPG4/SPAST | |||
SPG3A/ATLASTIN1 | Unknown | 7 % (after exclusion of SPG4 mutations) [13] | |
SPG31/REEP1 | 2 % [65] | ||
SPG10/KIF5A | None detected | Unknown | |
SPG8/KIAA0196 | Unknown | Unknown | |
SPG12/RTN2 | Rare [71] | Rare | Rare |
SPG6/NIPA1 | Unknown | Rare [72] | |
SPG13/HSPD1 | Rare | Unknown | Unknown |
SPG42/SLC33A1 | Unknown (single family only) | Unknown | Unknown |
SPG5A/CYP7B1 | 7 % of AR-pure HSP 1 reported AD family [30] | 3 % [30] | Unknown |
SPG7 | Rare cause of AR-pure HSP |
Complex HSP phenotypes
HSP with thin corpus callosum
HSP with cerebellar ataxia
Investigation of a patient with suspected HSP
Definition of phenotype, inheritance and exclusion of other causes
Structural and vascular | |
Arterio-venous dural fistula [77] | MRI/angiogram |
Spinal or parasagittal tumour | MRI |
Spondylosis | MRI |
Inflammatory | |
Multiple Sclerosis | MRI, CSF |
Vasculitic Myelopathy [36] | Autoimmune profile |
Stiff person syndrome [78] | Neurophysiology, antibody testing |
Sarcoidosis [79] | MRI, CSF, chest X-ray |
Metabolic (acquired and hereditary) | |
Vitamin deficiency (B12, E) | Vitamin levels |
Nitrous oxide toxicity [80] | History, B12 level |
White cell enzymes, VLCFA, MRI | |
Copper deficiency myelopathy [83] | Copper levels |
Degenerative | |
Primary lateral sclerosis | Neurophysiology and evolution of clinical picture |
Infectious | |
Tropical spastic paraparesis [37] | HTLV—1 serology, CSF |
HIV myelopathy [38] | HIV serology, CSF |
Syphilis | Syphilis serology, CSF |
Other | |
Radiation myelopathy [84] | History, imaging |
Spinocerebellar ataxias and other genetic conditions (see text and [39]) | Genetic testing. Trial of l-dopa |